On December 23–24, the 12th China Maternal and Child Health Conference organized by the China Maternal and Child Health Association was successfully held at the Fuzhou Strait International Conference & Exhibition Center. At this leading maternal and child health industry event, KFBIO showcased its AI-powered cervical cancer screening solution and comprehensive digital pathology platform, drawing keen interest from healthcare institutions and experts nationwide.

As China begins to implement its national maternal and child health plan in 2021, experts and scholars from across the country gathered in Rongcheng to explore key topics including healthcare reform trends, policy direction, information management, talent development, specialty advancement, digital pathology in maternal and child health, and technological innovation. The discussions aimed to promote high-quality development in maternal and child healthcare nationwide.

At the conference, Ningbo Konfoong Bioinformation Tech Co., Ltd. (KFBIO) showcased its comprehensive digital pathology solutions and AI-assisted cervical cancer screening system, drawing significant interest from maternal and child healthcare institutions and regional distributors. Attendees expressed strong recognition of KFBIO’s product quality and the promising application prospects of digital pathology in maternal and child health settings.

AI‑Driven Cervical Cancer Screening Supports Maternal & Child Healthcare Institutions

To address challenges such as low cervical cancer screening coverage among Chinese women, a severe shortage of cytopathologists, low screening efficiency, and inconsistent quality control, KFBIO has positioned AI‑assisted pathology diagnosis as an innovative breakthrough. The company offers an integrated end‑to‑end solution that covers:

• Gynecological sample collection
• Slide preparation and staining
• Digital scanning
• AI‑powered analysis
• Manual review
• Report generation

This holistic approach helps primary maternal and child healthcare institutions enhance their service capacity and quality.

1. Standardized Sample Collection & Tracking
KFBIO’s independently developed liquid‑based cytology sampling kit allows healthcare providers to scan a code using terminal equipment, linking sample information directly to provincial health platforms. This ensures standardized collection and real‑time quality control from the very first step.

2. High‑Quality Slide Preparation & Staining
The process utilizes advanced natural sedimentation technology and automated staining systems to effectively remove interfering components, ensuring consistent slide quality and improving positive detection rates.

3. Efficient Digitization with High‑Throughput Scanning
Using advanced line‑scanning technology and the KF‑TCT‑400 high‑throughput scanner, cervical cytology slides are rapidly converted into high‑resolution digital images. This enables digital reading, archiving, and easy retrospective analysis and quality monitoring.

4. Accurate AI‑Based Analysis
The system employs a recognition algorithm based on a deep learning neural network (DNN), trained with annotations from authoritative pathologists. It automatically identifies suspected lesions with high sensitivity and specificity, supporting consistent and efficient screening.

The KFBIO AI analysis system achieves a negative exclusion rate of over 60% and a positive detection rate of 98%, significantly reducing the initial screening workload in hospitals. Experts need only review slides and cells flagged by the system, greatly improving diagnostic efficiency and accuracy while promoting standardized diagnosis.

Driving Innovation in Maternal & Child Pathology

As a leader in end‑to‑end digital pathology solutions, KFBIO continues to prioritize innovation. By integrating artificial intelligence, remote diagnosis platforms, and other advanced technologies, the company is committed to enhancing pathology diagnostic capabilities, optimizing clinical services, and supporting the development of maternal and child pathology—ultimately contributing to the health and wellbeing of women and children.